RetractedArticleNature communications2018

Targeting 17q23 amplicon to overcome the resistance to anti-HER2 therapy in HER2+ breast cancer.

Yunhua Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.